Ginsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagy

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Yang, Zhiqing ^a   Zhao, Tingting ^a   Liu, Hongli ^a   Zhang, Leida ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; GINSENOSIDE; GINSENOSIDE RH 2;

ANIMAL; AUTOPHAGY; CANCER STEM CELL; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AUTOPHAGY; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION; GINSENOSIDES; HUMANS; LIVER NEOPLASMS; MICE; NEOPLASTIC STEM CELLS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84955282985     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep19383     Document Type: Article

References (43)

1. Wang, L., Yao, M., Dong, Z., Zhang, Y. & Yao, D. Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring. Tumour Biol 35, 9-20, doi: 10.1007/s13277-013-1141-0 (2014).
2. Wang, H. & Chen, L. Tumor microenviroment and hepatocellular carcinoma metastasis. J Gastroenterol Hepatol 28 Suppl 1, 43-48, doi: 10.1111/jgh.12091 (2013).
3. Han, M. S. et al. Brain metastasis from hepatocellular carcinoma: the role of surgery as a prognostic factor. BMC Cancer 13, 567, doi: 10.1186/1471-2407-13-567 (2013).
4. Petersson, M. & Niemann, C. Stem cell dynamics and heterogeneity: implications for epidermal regeneration and skin cancer. Curr Med Chem 19, 5984-5992 (2012).
5. Perez-Losada, J. & Balmain, A. Stem-cell hierarchy in skin cancer. Nat Rev Cancer 3, 434-443, doi: 10.1038/nrc1095 (2003).
6. Ma, S. Biology and clinical implications of CD133(+ ) liver cancer stem cells. Exp Cell Res 319, 126-132, doi: 10.1016/j. yexcr.2012.09.007 (2013).
7. Ma, S., Lee, T. K., Zheng, B. J., Chan, K. W. & Guan, X. Y. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 27, 1749-1758, doi: 10.1038/sj.onc.1210811 (2008).
8. Suetsugu, A. et al. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 351, 820-824, doi: 10.1016/j.bbrc.2006.10.128 (2006).
9. Ma, S. et al. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 6, 1146-1153, doi: 10.1158/1541-7786.MCR-08-0035 (2008).
10. Green, D. R. & Levine, B. To be or not to be How selective autophagy and cell death govern cell fate. Cell 157, 65-75, doi: 10.1016/j. cell.2014.02.049 (2014).
11. Guo, J. Y., Xia, B. & White, E. Autophagy-mediated tumor promotion. Cell 155, 1216-1219, doi: 10.1016/j.cell.2013.11.019 (2013).
12. White, E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12, 401-410, doi: 10.1038/nrc3262 (2012).
13. Levine, B. & Kroemer, G. Autophagy in the pathogenesis of disease. Cell 132, 27-42, doi: 10.1016/j.cell.2007.12.018 (2008).
14. Jia, Z. et al. Autophagy eliminates cytoplasmic beta-catenin and NICD to promote the cardiac differentiation of P19CL6 cells. Cell Signal 26, 2299-2305, doi: 10.1016/j.cellsig.2014.07.028 (2014).
15. Fu, Y. et al. Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/beta-catenin signaling pathway. PLoS One 9, e102535, doi: 10.1371/journal.pone.0102535 (2014).
16. Liu, D. et al. Atorvastatin Protects Vascular Smooth Muscle Cells From TGF-beta1-Stimulated Calcification by Inducing Autophagy via Suppression of the beta-Catenin Pathway. Cell Physiol Biochem 33, 129-141, doi: 10.1159/000356656 (2014).
17. Petherick, K. J. et al. Autolysosomal beta-catenin degradation regulates Wnt-autophagy-p62 crosstalk. EMBO J 32, 1903-1916, doi: 10.1038/emboj.2013.123 (2013).
18. Chang, H. W. et al. Knockdown of beta-catenin controls both apoptotic and autophagic cell death through LKB1/AMPK signaling in head and neck squamous cell carcinoma cell lines. Cell Signal 25, 839-847, doi: 10.1016/j.cellsig.2012.12.020 (2013).
19. Nguyen, T. M. et al. Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and beta-catenin levels. J Cell Mol Med 13, 3687-3698, doi: 10.1111/j.1582-4934.2009.00722.x (2009).
20. Clevers, H. & Nusse, R. Wnt/beta-catenin signaling and disease. Cell 149, 1192-1205, doi: 10.1016/j.cell.2012.05.012 (2012).
21. Ye, H., Wu, Q., Zhu, Y., Guo, C. & Zheng, X. Ginsenoside Rh2 alleviates dextran sulfate sodium-induced colitis via augmenting TGFbeta signaling. Mol Biol Rep 41, 5485-5490, doi: 10.1007/s11033-014-3422-0 (2014).
22. Kikuchi, Y. et al. Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo. Anticancer Drugs 2, 63-67 (1991).
23. Tode, T. et al. [Inhibitory effects of oral administration of ginsenoside Rh2 on tumor growth in nude mice bearing serous cyst adenocarcinoma of the human ovary]. Nihon Sanka Fujinka Gakkai zasshi 45, 1275-1282 (1993).
24. Tode, T. et al. Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice. J Cancer Res Clin Oncol 120, 24-26 (1993).
25. Nakata, H. et al. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn J Cancer Res 89, 733-740 (1998).
26. Tang, X. P., Tang, G. D., Fang, C. Y., Liang, Z. H. & Zhang, L. Y. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells. World J Gastroenterol 19, 1582-1592, doi: 10.3748/wjg.v19.i10.1582 (2013).
27. Liu, J. et al. Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells. Fitoterapia 81, 902-905, doi: 10.1016/j.fitote.2010.05.020 (2010).
28. Li, B. et al. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett 301, 185-192, doi: 10.1016/j.canlet.2010.11.015 (2011).
29. Oh, M. et al. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol 14, 869-875 (1999).
30. Choi, S., Kim, T. W. & Singh, S. V. Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of cyclin-dependent kinases. Pharm Res 26, 2280-2288, doi: 10.1007/s11095-009-9944-9 (2009).
31. Li, S. et al. EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2. Tumour Biol 35, 5593-5598, doi: 10.1007/s13277-014-1739-x (2014).
32. Zhu, L., Zhang, W., Wang, J. & Liu, R. Evidence of CD90+ CXCR4+ cells as circulating tumor stem cells in hepatocellular carcinoma. Tumour Biol, doi: 10.1007/s13277-015-3196-6 (2015).
33. Wang, M. et al. A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells. J Biol Chem 283, 18678-18684, doi: 10.1074/jbc.M801855200 (2008).
34. Yin, Y. C. et al. Clozapine induces autophagic cell death in non-small cell lung cancer cells. Cell Physiol Biochem 35, 945-956, doi: 10.1159/000369751 (2015).
35. Ajabnoor, G. M., Crook, T. & Coley, H. M. Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells. Cell death & disease 3, e260, doi: 10.1038/cddis.2011.139 (2012).
36. Bommareddy, A. et al. Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells. Cancer Res 69, 3704-3712, doi: 10.1158/0008-5472.CAN-08-4344 (2009).
37. Fazi, B. et al. Fenretinide induces autophagic cell death in caspase-defective breast cancer cells. Autophagy 4, 435-441 (2008).
38. Kim, W., Kim, M. & Jho, E. H. Wnt/beta-catenin signalling: from plasma membrane to nucleus. Biochem J 450, 9-21, doi: 10.1042/BJ20121284 (2013).
39. Yook, J. I. et al. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol 8, 1398-1406, doi: 10.1038/ncb1508 (2006).
40. Liu, W. et al. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet 26, 146-147, doi: 10.1038/79859 (2000).
41. Gewirtz, D. A. Autophagy and senescence in cancer therapy. J Cell Physiol 229, 6-9, doi: 10.1002/jcp.24420 (2014).
42. Gao, C. et al. Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation. Nat Cell Biol 12, 781-790, doi: 10.1038/ncb2082 (2010).
43. Zhang, Y. et al. GABARAPL1 negatively regulates Wnt/beta-catenin signaling by mediating Dvl2 degradation through the autophagy pathway. Cell Physiol Biochem 27, 503-512, doi: 10.1159/000329952 (2011).